(floo TIK a sone)
ArmonAir RespiClick and Arnuity Ellipta: Maintenance treatment of asthma as prophylactic therapy in patients ≥5 years (Arnuity Ellipta) or ≥12 years (ArmonAir RespiClick).
Flovent Diskus and Flovent HFA: Maintenance treatment of asthma as prophylactic therapy in patients ≥4 years.
Limitations of use: Not indicated for relief of acute bronchospasm.
Guideline recommendations: A low-dose inhaled corticosteroid (in addition to an as-needed short acting beta2-agonist) is the initial preferred long-term control medication for children, adolescents, and adult patients with persistent asthma who are candidates for treatment according to a step-wise treatment approach (GINA 2018; NAEPP 2007).
Sign up for a 10-day FREE Trial now and receive full access to all content.